產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
---|---|---|---|---|---|---|---|
110211-25MG |
|
956610-76-7 |
(R)-VANOL 磷酸酯 (6aR)-14-Hydroxy-6,7-diphenyl-14-oxide-dinaphtho[1,2-d:2',1'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C32H21O4P | |
110192-1G |
|
871130-17-5 |
(S)-VAPOL 磷酸酯 (8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C40H25O4P | |
110192-100MG |
|
871130-17-5 |
(S)-VAPOL 磷酸酯 (8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C40H25O4P | |
110192-25MG |
|
871130-17-5 |
(S)-VAPOL 磷酸酯 (8aS)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C40H25O4P | |
110191-1G |
|
871130-18-6 |
(R)-VAPOL 磷酸酯 (8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C40H25O4P | |
110191-100MG |
|
871130-18-6 |
(R)-VAPOL 磷酸酯 (8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C40H25O4P | |
110191-25MG |
|
871130-18-6 |
(R)-VAPOL 磷酸酯 (8aR)-18-Hydroxy-8,9-diphenyl-18-oxide-diphenanthro[4,3-d:3',4'-f][1,3,2]dioxaphosphepin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C40H25O4P | |
137842-1G |
|
NA |
(S)-6,6'-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C49H35O4P | |
137842-100MG |
|
NA |
(S)-6,6'-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C49H35O4P | |
137842-25MG |
|
NA |
(S)-6,6'-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C49H35O4P | |
137841-1G |
|
NA |
(R)-6,6'-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C49H35O4P | |
137841-100MG |
|
NA |
(R)-6,6'-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C49H35O4P | |
137841-25MG |
|
NA |
(R)-6,6'-雙[4-?(2-?萘基)?苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C49H35O4P | |
137792-1G |
|
NA |
(S)-6,6'-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C35H35O4P | |
137792-100MG |
|
NA |
(S)-6,6'-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C35H35O4P | |
137792-25MG |
|
NA |
(S)-6,6'-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C35H35O4P | |
137791-1G |
|
1801196-27-9 |
(R)-6,6'-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C35H35O4P | |
137791-100MG |
|
1801196-27-9 |
(R)-6,6'-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C35H35O4P | |
137791-25MG |
|
1801196-27-9 |
(R)-6,6'-雙(2,4,6-三甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C35H35O4P | |
137782-1G |
|
NA |
(S)-6,6'-雙[(3,5-二叔丁基-4-甲氧基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C47H59O6P | |